CAS 137525-51-0
:BPC 157
Descrição:
BPC 157, ou Composto de Proteção Corporal 157, é um peptídeo sintético composto por 15 aminoácidos. É derivado de uma proteína encontrada no suco gástrico e é conhecido por suas potenciais propriedades regenerativas e curativas. BPC 157 despertou interesse nos campos da medicina e do esporte por sua suposta capacidade de promover a cicatrização de tendões e ligamentos, melhorar a recuperação muscular e reduzir a inflamação. Acredita-se que seu mecanismo de ação envolva a modulação de fatores de crescimento e a promoção da angiogênese, que é a formação de novos vasos sanguíneos. Além disso, BPC 157 mostrou potenciais efeitos neuroprotetores e pode ajudar na saúde gastrointestinal. Embora a pesquisa esteja em andamento, é importante notar que BPC 157 não é aprovado para uso humano por agências reguladoras, e sua segurança e eficácia em ambientes clínicos ainda precisam ser totalmente estabelecidas. Assim como com qualquer peptídeo ou suplemento, os indivíduos devem ter cautela e consultar profissionais de saúde antes de usar.
Fórmula:C62H98N16O22
InChI:InChI=1/C62H98N16O22/c1-31(2)25-37(55(92)74-50(32(3)4)62(99)100)71-46(81)29-65-51(88)33(5)67-53(90)38(26-48(84)85)73-54(91)39(27-49(86)87)72-52(89)34(6)68-57(94)41-15-10-21-75(41)58(95)35(13-7-8-20-63)70-45(80)30-66-56(93)40-14-9-22-76(40)60(97)43-17-12-24-78(43)61(98)42-16-11-23-77(42)59(96)36(18-19-47(82)83)69-44(79)28-64/h31-43,50H,7-30,63-64H2,1-6H3,(H,65,88)(H,66,93)(H,67,90)(H,68,94)(H,69,79)(H,70,80)(H,71,81)(H,72,89)(H,73,91)(H,74,92)(H,82,83)(H,84,85)(H,86,87)(H,99,100)/t33-,34-,35?,36-,37-,38-,39-,40-,41-,42-,43-,50-/m0/s1
SMILES:CC(C)C[C@@H](C(=N[C@@H](C(C)C)C(=O)O)O)N=C(CN=C([C@H](C)N=C([C@H](CC(=O)O)N=C([C@H](CC(=O)O)N=C([C@H](C)N=C([C@@H]1CCCN1C(=O)C(CCCCN)N=C(CN=C([C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)N=C(CN)O)O)O)O)O)O)O)O)O
Sinónimos:- Booly protection compound 15
- Bpc 15
- L-Valine, glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-
- glycyl-L-alpha-glutamyl-L-prolyl-L-prolyl-L-prolylglycyllysyl-L-prolyl-L-alanyl-L-alpha-aspartyl-L-alpha-aspartyl-L-alanylglycyl-L-leucyl-L-valine
- Bpc 157
- Bpc-157
- peptide BPC157
- Pentadecapetide
- BPC 157 USP/EP/BP
- pentadecapeptide BPC
- Peptide Powder BPC 157
- L-Valine, glycyl-L-a-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-a-aspartyl-L-a-aspartyl-L-alanylglycyl-L-leucyl-
- Bepecin
- High Quality Peptides Peptide Ace 031 Ace-031 Ace031 for Bodybuilding
- Pharmaceutical Peptide Peptides Pentadecapeptide Bpc157 Bpc 157 5mg/Vials 2mg/Vials
- High Quality Bpc-157 Arg Bpc157 for Research White Powder
- BPC 157 (Booly protection compound 15)
- peptides bpc157
- PENTADECAPEPTIDE
- Injectable Lyophillzed Powder Peptides Peptide Adipotide 20mg/Vial
- GEPPPGKPADDAGLV
- L-Valine, glycyl-L-α-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-α-aspartyl-L-α-aspartyl-L-alanylglycyl-L-leucyl-
- Ver mais sinónimos
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
4 produtos.
Gastric Juice Peptide Fragment
CAS:The pentadecapeptide BPC-157 (GEPPPGKPADDAGLV) shows a protective effect on stomach and duodenum when administered to stress ulcers, cysteamine-duodenal ulcers and ethanol lesions. Application of BPC 157 improved tendon healing.Fórmula:C62H98N16O22Pureza:96.1%Cor e Forma:White - WhitishPeso molecular:1419.56BPC 157 trifluoroacetate
CAS:Produto Controlado<p>Body Protecting Compound (BPC) 157 is a pentadecapeptide gut peptide with free radical scavenging activity. As a gastric juice pentadecapeptide fragment, BPC 157 stimulates nitric oxide synthase generation, offering significant gastric cytoprotection. It has been shown to heal lesions in experimental models of bowel disease, Unlike many other peptides, BPC 157 effectively acts without a carrier, notably aiding in muscle healing, such as in the treatment of gastrocnemius muscle complex injuries. BPC 157 is also an anti-inflammatory agent that has been shown to have clinical relevance in patients with congestive heart failure. BPC 157 has been shown to inhibit inflammation by blocking the production of proinflammatory mediators such as prostaglandins and leukotrienes. It also suppresses the production of proinflammatory cytokines such as tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β). BPC 157 also downregulates genes that are involved in liver fibrosis, which may account for its efficacy in patients with liver cirrhosis. BPC 157 increases the production of hepatocyte growth factors (HGFs), which stimulate cell proliferation and promote tissue repair. It also upregulates genes involved in wound healing. Additionally, BPC 157 displays antianxiety and antidepressant effects. At the cellular level, it fosters proliferation, migration, and tube formation in human umbilical vein endothelial cells by activating ERK1/2 phosphorylation.</p>Fórmula:C62H98N16O22•(C2HF3O2)xPureza:Min. 95%Cor e Forma:PowderPeso molecular:1,419.53 g/mol




